Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series
Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for...
Main Authors: | Enfield, K.B (Author), Hulse, M.C (Author), Konkol, S.B (Author), Mihalek, A.D (Author), Morrisette, M.J (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
by: Brian Ayers, et al.
Published: (2020-09-01) -
Definitions and pathophysiology of vasoplegic shock
by: Simon Lambden, et al.
Published: (2018-07-01) -
Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
by: Laurence W. Busse, et al.
Published: (2020-02-01) -
Vasoresponsiveness in patients with heart failure (VASOR): protocol for a prospective observational study
by: Marieke E. van Vessem, et al.
Published: (2019-11-01) -
Efficacy of methylene blue for on vasoplegic syndrome
by: Mohsen akhondi, et al.
Published: (2016-04-01)